Pharma's New Top Lobbyist Is Former Majority Leader Eric Cantor
The Pharmaceutical Research and Manufacturers of America, one of the most powerful lobbies in Washington, has selected former House Republican Majority Leader Eric Cantor as its next president.
Cantor, a Virginia Republican who served as House majority leader from 2011 to 2014, will lead the trade group for branded drugmakers as it navigates growing scrutiny from the Trump administration and Congress over its pricing practices, as well as increasing competition from China. Cantor, who starts on Nov. 9, has served as vice chair and managing director at Moelis & Company, an investment bank, since his defeat in a 2014 primary to a tea party-backed challenger, Dave Brat.
Cantor was the first sitting majority leader in history to a lose a party primary.
Cantor will succeed Stephen Ubl, who announced his decision to step down earlier this year. Rob Davis, chief executive of Merck and PhRMA’s board chair, said Cantor’s “global business acumen coupled with policy and political experience at the highest levels of government make him an ideal person to lead PhRMA during this critical next chapter.”
Popular Products
-
Classic Oversized Teddy Bear$23.78 -
Gem's Ballet Natural Garnet Gemstone ...$171.56$85.78 -
Butt Lifting Body Shaper Shorts$95.56$47.78 -
Slimming Waist Trainer & Thigh Trimmer$67.56$33.78 -
Realistic Fake Poop Prank Toys$99.56$49.78